Yale Cancer Center
S

Identifying and Targeting DNA Repair Mutations in Cancer

By Yale Cancer Center FEATURING Shridar Ganesan
By Yale Cancer Center FEATURING Shridar Ganesan
9 views
October 14, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy

Related Content

AUTOPLAY
33:44
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive &a…

Feat. S. Tolaney, H. Rugo
23:17
University of Miami Sylvester Comprehensive Cancer Center

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

Feat. D. Tripathy
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

Feat. V. Subbiah
15:11
Insights from 2024 ACP Annual Meeting

ACP 2024 Insights: Cancer of Unknown Primary

Feat. S. Brondfield
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
27:15
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Management of Higher Risk eBC Including BR…

Feat. M. Dolezal
55:10
University of Colorado Cancer Center

History of Cancer and Its Treatment: What Will It Take to Cure?

Feat. C. Lieu
15:22
2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

Feat. S. Ogino
38:47
Medical College of Georgia - Augusta University

Oncologic Emergencies: The Clock Is Ticking

Feat. G. Raval
07:34
PrecisCa

Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Anal…

Feat. M. Pegram
06:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of C…

Feat. A. Medford
08:48
James Martin

2L Therapy for ER+ mBC Following CDK4/6i

22:36
UChicago Medicine

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

Feat. A. Cooper
41:07
Yale Cancer Center

Understanding Your Cancer Risk and Options for Cancer Prevention

Feat. V. Giri, T. Shroff
15:10
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

NGS in Glioblastoma: Clinically Relevant Genomics

Feat. J. Morrissette
23:00
Total Health

ctDNA and MRD: Who, What, and Then What?

Feat. A. Parikh
17:57
UChicago Medicine

Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC

Feat. R. Nanda
46:03
University of Colorado Cancer Center

CAR NK Cells: Next Generation Cell Therapies for Cancer

Feat. K. Rezvani
33:35
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Developing Novel Therapeutics for Brain Tumors in the Age of Genomic…

Feat. E. Galanis